Buy acomplia online - Cheap acomplia pills |
|||||||||||||||
![]() |
![]() |
![]() |
|||||||||||||
RETURN HOME | |||||||||||||||
![]() | |||||||||||||||
|
|||||||||||||||
Rimonabant Acomplia Helps With Weight Loss Rimonabant acomplia is an anorectic anti obesity drug. It is a CB1 cannabinoid receptor antagonist. Its main avenue of effect is reduction in appetite. Obesity is now the most common nutritional disorder in western countries. Defined as a body mass index of greater than 30, it arises from the accumulation of excess fat in the body from overconsumption of fatty foods. Prevalence of obesity in the US and Europe has reached epidemic levels. Data from the World Health Organisation's MONICA project show that in some parts of Europe over 70% of men aged 55-64 years are clinically obese or overweight (BMI >25) and almost 70% of women in this age group. One in five of all Americans is obese and one in three overweight. Furthermore, increasing rates of childhood obesity are likely to exacerbate the trend towards increasing obesity in adulthood. Rimonabant Acomplia Rimonabant acomplia in clinical test also found to be effective in assisting some smokers to quit smoking. There is a direct relation between obesity and increased risk of cardiovascular disease and diabetes and possibly certain cancers, such as breast and colorectal cancer. Increases in body weight lead to changes in blood lipid and cholesterol levels, predisposing to increased risk of atherosclerosis. Rimonabant acomplia has been developed from the knowledge that cannabis smokers often experience extreme hunger pangs, which cannabis smokers refer to as 'the munchies'. Rimonabant acomplia the most advanced of any anti-obesity drug in testing and so far, preliminary data from large studies have shown that weight loss is more dramatic than with existing drugs. |
|||||||||||||||